Name | Regina Hospital |
---|---|
Type | Acute Care Hospital |
Location | 1175 Nininger Road, Hastings, Minnesota |
Ownership | Voluntary non-profit - Church |
Emergency Services | Yes |
Medicare ID (CCN) | 240059 |
NPI Number | 1326066085 |
Organization Name | REGINA MEDICAL CENTER |
Address | 1175 Nininger Rd, Hastings, MN 55033 |
Hospital Type | General Acute Care Hospital |
Phone Number | 651-480-4100 |
News Archive
Incyte Corporation announced today positive results from an ongoing Phase I/II clinical trial for its selective oral sheddase inhibitor, INCB7839, involving 46 patients with HER2 positive metastatic breast cancer.
Countries must set ambitious national climate commitments if they are to sustain a healthy and green recovery from the COVID-19 pandemic.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Cyclobenzaprine Hydrochloride (HCl) Extended-release (ER) Capsules, 15 mg and 30 mg. Mylan was the first company to have filed a substantially complete ANDA containing a Paragraph IV certification for Cyclobenzaprine HCl ER Capsules and was awarded 180 days of marketing exclusivity.
UC Irvine's Department of Anesthesiology & Perioperative Care has been awarded a Picker Institute/Gold Foundation Challenge Grant to change how anesthesiologists are trained, emphasizing the skills necessary to treat patients with compassion and empathy under difficult conditions.
Developing drugs to combat or cure human disease often involves a phase of testing with mice, so being able to peer clearly into a living mouse's innards has real value.
› Verified 3 days ago
NPI Number | 1508457045 |
Organization Name | ALLINA HEALTH SYSTEM |
Doing Business As | ALLINA HEALTH CANCER INSTITUTE - HASTINGS |
Address | 1175 Nininger Rd Ste B1, Hastings, MN 55033 |
Hospital Type | General Acute Care Hospital |
Phone Number | 651-404-1000 |
News Archive
Incyte Corporation announced today positive results from an ongoing Phase I/II clinical trial for its selective oral sheddase inhibitor, INCB7839, involving 46 patients with HER2 positive metastatic breast cancer.
Countries must set ambitious national climate commitments if they are to sustain a healthy and green recovery from the COVID-19 pandemic.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Cyclobenzaprine Hydrochloride (HCl) Extended-release (ER) Capsules, 15 mg and 30 mg. Mylan was the first company to have filed a substantially complete ANDA containing a Paragraph IV certification for Cyclobenzaprine HCl ER Capsules and was awarded 180 days of marketing exclusivity.
UC Irvine's Department of Anesthesiology & Perioperative Care has been awarded a Picker Institute/Gold Foundation Challenge Grant to change how anesthesiologists are trained, emphasizing the skills necessary to treat patients with compassion and empathy under difficult conditions.
Developing drugs to combat or cure human disease often involves a phase of testing with mice, so being able to peer clearly into a living mouse's innards has real value.
› Verified 3 days ago
NPI Number | 1841627387 |
Organization Name | ALLINA HEALTH SYSTEM |
Doing Business As | ALLINA HEALTH REGINA HOSPITAL |
Address | 1175 Nininger Rd, Hastings, MN 55033 |
Hospital Type | General Acute Care Hospital |
Phone Number | 651-404-1244 |
News Archive
Incyte Corporation announced today positive results from an ongoing Phase I/II clinical trial for its selective oral sheddase inhibitor, INCB7839, involving 46 patients with HER2 positive metastatic breast cancer.
Countries must set ambitious national climate commitments if they are to sustain a healthy and green recovery from the COVID-19 pandemic.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Cyclobenzaprine Hydrochloride (HCl) Extended-release (ER) Capsules, 15 mg and 30 mg. Mylan was the first company to have filed a substantially complete ANDA containing a Paragraph IV certification for Cyclobenzaprine HCl ER Capsules and was awarded 180 days of marketing exclusivity.
UC Irvine's Department of Anesthesiology & Perioperative Care has been awarded a Picker Institute/Gold Foundation Challenge Grant to change how anesthesiologists are trained, emphasizing the skills necessary to treat patients with compassion and empathy under difficult conditions.
Developing drugs to combat or cure human disease often involves a phase of testing with mice, so being able to peer clearly into a living mouse's innards has real value.
› Verified 3 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Incyte Corporation announced today positive results from an ongoing Phase I/II clinical trial for its selective oral sheddase inhibitor, INCB7839, involving 46 patients with HER2 positive metastatic breast cancer.
Countries must set ambitious national climate commitments if they are to sustain a healthy and green recovery from the COVID-19 pandemic.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Cyclobenzaprine Hydrochloride (HCl) Extended-release (ER) Capsules, 15 mg and 30 mg. Mylan was the first company to have filed a substantially complete ANDA containing a Paragraph IV certification for Cyclobenzaprine HCl ER Capsules and was awarded 180 days of marketing exclusivity.
UC Irvine's Department of Anesthesiology & Perioperative Care has been awarded a Picker Institute/Gold Foundation Challenge Grant to change how anesthesiologists are trained, emphasizing the skills necessary to treat patients with compassion and empathy under difficult conditions.
Developing drugs to combat or cure human disease often involves a phase of testing with mice, so being able to peer clearly into a living mouse's innards has real value.
› Verified 3 days ago
Regina Hospital Acute Care Hospital Location: 1175 Nininger Road, Hastings, Minnesota 55033 Phone: (651) 480-1000 |